GH Research PLC (GHRS): Net earnings per share for the last 12 months

Symbol and logo of brand GH Research PLC (GHRS)

GH Research PLC (GHRS) is at the beginning of a global scientific and technological cycle where asset value is tied to clinical success. The change in the rolling annual EPS demonstrates this trend, and the value of -0.99 corresponds to the current metric. Growth is driven by the automation of substance synthesis, although physicians maintain patient control. However, threats from DEA regulators and the lack of patent protection for methods remain.

GHRS (GH Research Group) Net earnings per share for the last 12 months history from 07/04/2022 to 11/15/2026

Analytical breakdowns and data insights for company GH Research Corp (GHRS)

- current quotes and average value forecast:
Comprehensive company analysis:GH Research (GHRS)
Mass-produced product of GH Research plc

This indicator reflects the portion of net income attributable to a single ordinary share over the last twelve months, allowing for an assessment of real capital generation efficiency. By analyzing the fundamental TTM earnings per share, an investor can see the impact of high R&D expenses at GH Research PLC (GHRS), which temporarily reduce current yields pending the publication of Phase 2 clinical trial results.